Name

Eligard

Alternate Names

Lupron
Leuprolide Acetate

Abbreviations

None

Category

Hormones and hormonal mechanisms

Subcategory

LHRH

NSC Number

None

Primary Site

Prostate cancer
Breast

Histology

None

Remarks

December 2016 Update: Lupron as ovarian suppressor in pre-menopausal breast cancer has been approved by the FDA per NCI. Beginning with cases diagnosed 1/1/2017 forward, code as hormone therapy.

Lupron is a gonadotropin-releasing hormone analogue. FDA approved its use on prostate cancer and should be coded as hormone therapy.

FOR BREAST CASES DIAGNOSED 1/1/2017 FORWARD: Code as hormone treatment

Coding

This drug should be coded
Glossary